Overbought Stocks · Biological Products, (No Diagnostic Substances)
8 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–8 of 8
| TARS | Tarsus Pharmaceuticals, Inc. | 0.12 | 4.19 | +15.26% | +27.07% | +21.03% | Death | 78.90 | 92.7% | Bullish | Buy | -2.50% | +72.25% | -2.09% | Channel Up | — | 83.12 | +0.41% |
| APGE | Apogee Therapeutics, Inc. | 0.32 | 0.39 | +0.23% | +0.71% | +46.88% | Golden | 77.64 | 98.4% | Bearish | Buy | -3.51% | +280.08% | +0.04% | Symmetrical Triangle | — | 135.08 | +0.04% |
| ALVO | Alvotech | 0.25 | 0.26 | +19.05% | +37.89% | +29.45% | Death | 74.57 | 94.1% | Bullish | Buy | -41.95% | +82.34% | +1.12% | — | Spinning Top | 5.37 | +0.56% |
| HALO | Halozyme Therapeutics, Inc. | 0.18 | 2.79 | +4.92% | +23.14% | +49.61% | Golden | 74.40 | 96.5% | Bearish | Buy | -0.40% | +80.82% | +1.00% | — | Doji | 110.73 | +1.01% |
| ATTO | Attovia Therapeutics, Inc. | -12.23 | 2.20 | +19.39% | +148.77% | — | — | 74.06 | 76.0% | Bearish | Neutral | -8.36% | +5656.82% | +3.48% | Channel Up | Doji | 25.33 | +3.56% |
| NVAX | Novavax Inc | 0.55 | 0.53 | +17.43% | +20.98% | +21.10% | Golden | 73.43 | 87.3% | Bullish | Buy | -13.62% | +66.51% | +0.78% | Channel Down | Spinning Top | 10.34 | +0.19% |
| CRDL | Cardiol Therapeutics Inc. | 0.46 | 0.13 | +15.70% | +49.85% | +79.60% | Golden | 72.19 | 78.3% | Bullish | Strong Buy | -5.07% | +144.89% | -1.39% | — | Spinning Top | 2.15 | -0.23% |
| IOVA | Iovance Biotherapeutics, Inc. | 0.33 | 0.53 | +14.58% | +51.65% | +125.83% | Golden | 70.31 | 78.9% | Bearish | Buy | -5.98% | +400.00% | +0.46% | Inverse Head and Shoulders | — | 8.80 | +2.09% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.
Cite this data: “Overbought Stocks”, tradmap.com, data as of 2026-09-18 — tradmap.com/screener/overbought.
Free to cite with attribution and a link.